SEC 13F Intelligence

Ecor1 Capital, LLC / ORIC

Ecor1 Capital, LLC’s Oric Pharmaceuticals Inc Position

Does Ecor1 Capital, LLC own Oric Pharmaceuticals Inc (ORIC)? Yes — 6.73M shares worth $85M (+3.62% of its 13F portfolio) as of Q1 2026.

Position Value
$85M
Q1 2026
Shares
6.73M
% of Portfolio
+3.62%
Quarters Held
24
currently held

Position History ORIC

Reported value by quarter
Q2 ’20: $89MQ2 ’20Q3 ’20: $66MQ4 ’20: $105MQ1 ’21: $76MQ1 ’21Q2 ’21: $55MQ3 ’21: $73MQ4 ’21: $51MQ4 ’21Q1 ’22: $18MQ2 ’22: $15MQ3 ’22: $11MQ3 ’22Q4 ’22: $20MQ1 ’23: $19MQ2 ’23: $27MQ2 ’23Q3 ’23: $21MQ4 ’23: $31MQ1 ’24: $47MQ1 ’24Q2 ’24: $24MQ3 ’24: $35MQ4 ’24: $28MQ4 ’24Q1 ’25: $19MQ2 ’25: $16MQ3 ’25: $81MQ3 ’25Q4 ’25: $55MQ1 ’26: $85Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20266.73M$85M+3.62%
Q4 20256.73M$55M+2.50%
Q3 20256.73M$81M+3.87%
Q2 20251.62M$16M+0.97%
Q1 20253.42M$19M+1.13%
Q4 20243.42M$28M+1.04%
Q3 20243.42M$35M+1.20%
Q2 20243.42M$24M+0.74%
Q1 20243.42M$47M+1.19%
Q4 20233.42M$31M+0.82%
Q3 20233.42M$21M+0.70%
Q2 20233.42M$27M+0.65%
Q1 20233.42M$19M+0.63%
Q4 20223.42M$20M+0.61%
Q3 20223.42M$11M+0.32%
Q2 20223.42M$15M+0.53%
Q1 20223.42M$18M+0.57%
Q4 20213.47M$51M+1.62%
Q3 20213.47M$73M+2.52%
Q2 20213.09M$55M+2.04%
Q1 20213.09M$76M+3.36%
Q4 20203.09M$105M+5.63%
Q3 20202.64M$66M+4.71%
Q2 20202.64M$89M+6.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ecor1 Capital, LLC’s full portfolio or all institutional holders of ORIC.